Current through the 2024 Fourth Special Session
Section 26B-4-209 - No effect on use of hemp extract - Cannabidiol - Approved drugs(1) Nothing in this part prohibits an individual from purchasing, selling, possessing, or using a cannabinoid product in accordance with Section 4-41-402.(2) Nothing in this part restricts or otherwise affects the prescription, distribution, or dispensing of a product that the United States Food and Drug Administration has approved.Renumbered from § 26-61a-113 and amended by Chapter 307, 2023 General Session ,§ 67, eff. 5/3/2023.Amended by Chapter 354, 2020 General Session ,§ 39, eff. 5/12/2020.Amended by Chapter 12, 2020 General Session ,§ 21, eff. 2/28/2020.Added by Chapter 1, 2018SP3 General Session ,§ 57, eff. 12/3/2018.